Aubrey Capital Management’s Axogen AXGN Stock Holding History

Aubrey Capital Management’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.56M	Buy	98,700 +11,700	+13%	+$472K	2.86%	11
2026 Q1	$2.88M	Buy	+87,000	New	+$2.83M	1.55%	25
2018 Q3	–	Sell	-72,500	Closed	-$3.27M	–	33
2018 Q2	$3.27M	Buy	+72,500	New	+$3.19M	1.53%	24

Other funds holding AXGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Aubrey Capital Management's AXGN Position: Q2 2026 in Review

Aubrey Capital Management increased its Axogen (AXGN) stake by 13% in Q2 2026, buying an estimated $472K and bringing the position to 98,700 shares worth $4.56M. The position accounts for 2.86% of the portfolio, ranked #11.

Aubrey Capital Management first reported a position in AXGN in Q2 2018 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

Aubrey Capital Management held 98,700 shares of Axogen worth $4.56M as of Q2 2026.
Aubrey Capital Management bought 11,700 Axogen shares in Q2 2026, an estimated $472K.
Axogen made up 2.86% of Aubrey Capital Management's portfolio in Q2 2026, its #11 holding.
Aubrey Capital Management first reported a position in Axogen in Q2 2018 and has held it in 3 quarters since.
253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Aubrey Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.